Brief: DiaMedica Therapeutics Appoints Julie Daves As Svp, Clinical Development Operations
14/09/2022 13:48
Sept 14 (Reuters) - DiaMedica Therapeutics Inc DMAC.O :
* DIAMEDICA THERAPEUTICS APPOINTS JULIE DAVES AS SVP,
CLINICAL
DEVELOPMENT OPERATIONS
Source text for Eikon: ID:nBw3pSDJga
Further company coverage: DMAC.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on DiaMedica Therapeutics
See all newsBrief: Diamedica Therapeutics Announces Enrollment Of 200Th Patient In Remedy2 Phase 2/3 Acute Ischemic Stroke Trial
DiaMedica Q2 net loss widen less than expected
DiaMedica Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Qualcomm, Robinhood
Brief: Diamedica Receives FDA Feedback On Dm199 Preeclampsia Nonclinical Program